Evidence That Receptor Activator of Nuclear Factor (NF)-κB Ligand Can Suppress Cell Proliferation and Induce Apoptosis through Activation of a NF-κB-independent and TRAF6-dependent Mechanism

This publication has 75 references indexed in Scilit:

• c-Jun N-terminal Kinase Contributes to Apoptotic Synergy Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand plus DNA Damage in Chemoresistant, p53 Inactive Mesothelioma Cells
  Published by Elsevier ,2003
• Role of TRAF3 and -6 in the Activation of the NF-κB and JNK Pathways by X-linked Ectodermal Dysplasia Receptor
  Journal of Biological Chemistry, 2002
• Targeting death and decoy receptors of the tumour-necrosis factor superfamily
  Nature Reviews Cancer, 2002
• Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines
  Blood, 2001
• TROY, a Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily, Exhibits a Homology with Edar and Is Expressed in Embryonic Skin and Hair Follicles
  Journal of Biological Chemistry, 2000
• Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells
  Journal of Biological Chemistry, 2000
• Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)
  Journal of Biological Chemistry, 1998
• Requirement for NF-κB in osteoclast and B-cell development
  Genes & Development, 1997
• Identification of TRAF6, a Novel Tumor Necrosis Factor Receptor-associated Factor Protein That Mediates Signaling from an Amino-terminal Domain of the CD40 Cytoplasmic Region
  Published by Elsevier ,1996
• Identification of Interleukin 1-induced Apoptosis in Rat Islets Usingin situSpecific Labelling of Fragmented DNA
  Journal of Autoimmunity, 1996